(Total Views: 521)
Posted On: 10/13/2025 5:59:35 AM
Post# of 157994
Re: KenChowder #157840
This today in BioSpace: Good article
Nearly Three Quarters of FDA Breakthrough Designated Drugs Win Approval: Report
New analysis from Jefferies shows that rare disease and cancer drugs granted the status are especially likely to be approved.
https://www.biospace.com/fda/nearly-three-qua...val-report
Nearly Three Quarters of FDA Breakthrough Designated Drugs Win Approval: Report
New analysis from Jefferies shows that rare disease and cancer drugs granted the status are especially likely to be approved.
https://www.biospace.com/fda/nearly-three-qua...val-report
(6)
(0)
